跳至主要内容
临床试验/NCT02960347
NCT02960347已完成不适用

Examining the Efficacy of tDCS in the Attenuation of Epileptic Paroxysmal Discharges and Clinical Seizures

Herzog Hospital1 个研究点 分布在 1 个国家目标入组 1 人开始时间: 2016年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1
试验地点
1
主要终点
change in seizure frequency from baseline

研究概览

简要总结

The current study examined the feasibility of High-Definition tDCS (HD-tDCS) in reducing epileptiform activity in a 30-month-old child suffering from early onset epileptic encephalopathy. HD-tDCS was administered over 10 intervention days spanning two weeks including pre- and post-intervention video-electroencephalography (EEG) monitoring.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
10 Months 至 36 Months(Child)
性别
Male
接受健康志愿者
否

入选标准

  • •Initial diagnosis of Ohtahara syndrome/West syndrome/ Lennox-Gastaut syndrome by a pediatric neurologist using video-EEG
  • •Ongoing synchronous Hypsarrhythmia
  • •Modified Hypsarrhythmia with a consistent focus of paroxysmal discharges
  • •Signed informed consent of parents/immediate legal guardian
  • •Age 10 to 36 months
  • •Infant should be in a steady state indicated by a baseline test of electrolytes and biochemistry blood test, heart rate, temperature, respiratory rate, and saturation.

排除标准

  • •Metal in the cranium, skull defects, or skin lesions on scalp (cuts, abrasions, rash) at proposed electrode sites.
  • •History of adverse reaction to neurostimulation
  • •Significant ECG abnormality

研究组 & 干预措施

Active tDCS

Experimental

open label active tDCS treatment

干预措施: High-definition (HD) transcranial direct current stimulator, HD-tDCS with 4x1 HD adaptor (Device)

结局指标

主要结局

change in seizure frequency from baseline

时间窗: day 1, day 3, day 5, day 6, day 8, day 10, day 13, day 20, day 27, day 33, day 40, day 50

次要结局

未报告次要终点

研究者

发起方
Herzog Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验